News related to Acular (Ketorolac Ophthalmic) and/or conditions it is approved for
New lens effective treatment of dry AMD, established wet forms of AMD, other macular disease including maculopathy
Source: Eye Health / Blindness News From Medical News Today [2015.08.26]
Following revolutionary eye surgery at the London Eye Hospital to implant a state-of-the-art iolAMD lens in her eye, retired classroom assistant Irene Da Silva has realised her dream of seeing her...
Waterford research on Alzheimer's disease suggests that measuring macular pigment offers potential as a biomarker of cognitive health
Source: Eye Health / Blindness News From Medical News Today [2015.08.25]
Results to be showcased internationally in the Journal of Alzheimer's DiseaseOngoing European Research Council-funded research at Waterford Institute of Technology's (WIT) Macular Pigment...
Source: MedicineNet Cataracts Specialty [2015.05.07]
Title: Macular Degeneration
Category: Diseases and Conditions
Created: 7/23/1999 12:00:00 AM
Last Editorial Review: 5/7/2015 12:00:00 AM
Jetrea Gets FDA Nod for Macular Adhesion
Source: MedPage Today Product Alert [2012.10.19]
WASHINGTON -- The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion.
'Miniature Telescope' for Eye Approved for Macular Degeneration
Source: MedicineNet Macular Degeneration (Age-Related Type) Specialty [2010.07.07]
Title: 'Miniature Telescope' for Eye Approved for Macular Degeneration
Category: Health News
Created: 7/6/2010 2:10:00 PM
Last Editorial Review: 7/7/2010
Stem cells derived from amniotic membrane can benefit retinal diseases when transplanted
Source: Diabetes News From Medical News Today [2015.08.20]
Tests on animal models show that MSCs secrete growth factors that suppress causes of diabetic retinopathy and macular degenerationA team of researchers in South Korea has successfully...
Ruboxistaurin (RBX) may reduce risk of vision loss in diabetics
Source: The Doctors Lounge - Endocrinology and Diabetes
Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema.